The Food and Drug Administration yesterday amended its emergency use authorization for Pfizer’s updated COVID-19 vaccine to allow children aged 6 months through 4 to receive a single booster dose at least two months after completing three Pfizer monovalent vaccine doses. The agency has not yet authorized a Pfizer bivalent booster in children who received a bivalent dose for the third dose in the Pfizer primary vaccine series. 

“Currently available data show that vaccination remains the best defense against severe disease, hospitalization and death caused by COVID-19 across all age groups, and we encourage all eligible individuals to make sure that their vaccinations are up to date with a bivalent COVID-19 vaccine,” said Peter Marks, M.D., director of the FDA’s Center for Biologics Evaluation and Research. 

In other news, the FDA this week revised its fact sheets for health care providers administering and patients receiving the J&J COVID-19 vaccine to warn about increased risks for myocarditis and pericarditis, particularly in the first week after vaccination, as well as facial paralysis.

Related News Articles

Headline
Just in time for March Madness, AHA is offering for hospitals and health systems a social media toolkit that uses the wildly popular NCAA basketball tournament…
Headline
Completing the Moderna or Pfizer COVID-19 monovalent vaccine primary series protects children aged 3-5 and 3-4, respectively, against symptomatic SARS-CoV-2…
Headline
AHA is offering for hospitals and health systems a second social media toolkit for February with messages for promoting COVID-19 vaccination and boosters. The…
Headline
A new video from AHA and the Children’s Hospital Association is reminding the public how vaccines and boosters are safe, effective means for preventing…
Headline
In a new public service announcement, leaders of the AHA, American Medical Association and American Nurses Association encourage the public to get vaccinated…
Headline
When the omicron BA.4/BA.5 variants were circulating, Americans who received an updated COVID-19 vaccine were 14 times less likely to die than those who…